Neil Gallagher
CIK 1972849 · President, Head of R&D · last filed 2026-06-25
Neil Gallagher is a President, Head of R&D who has filed 11 SEC Form 4 insider transactions across 3 companies since 2023. The most recent filing, for FHTX, was dated Jun 25, 2026. Across all open-market trades the lifetime net is −$71.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.73M
3
11
-$71.6K
Holdings By Company
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2025-11-21 | ZYME | Notice (144) | −105,000 | -$2.50M | EDGAR |
| 2025-07-10 | SNDX | Notice (144) | −9,679 | -$89.7K | EDGAR |
| 2025-05-02 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2025-02-12 | SNDX | Sell (S) | −4,618 | -$71.6K | EDGAR |
| 2025-02-10 | SNDX | Notice (144) | −4,618 | -$71.6K | EDGAR |
| 2025-02-07 | SNDX | Grant (A) | +41,900 | $0 | EDGAR |
| 2024-12-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2024-04-02 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2024-02-09 | SNDX | Grant (A) | +47,813 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.